Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Balance Sheets

v3.22.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 287,511 $ 305,744
Accounts receivable, net 31,183 23,112
Inventory 16,137 9,862
Other receivables - related party 631 678
Prepaid expenses and other current assets 5,724 7,066
Total current assets 341,186 346,462
Property, plant and equipment, net 14,430 15,066
Operating lease right-of-use asset, net 18,565 19,005
Restricted cash 2,220 2,220
Intangible asset, net 30,457 12,552
Other assets 1,072 1,198
Total assets 407,930 396,503
Current liabilities    
Accounts payable and accrued expenses 91,268 90,660
Deferred revenue 2,034 2,611
Income taxes payable 346 345
Operating lease liabilities, short-term 2,129 2,104
Partner company line of credit 0 812
Partner company installment payments - licenses, short-term (net of imputed interest of $637 and $490 as of March 31, 2022 and December 31, 2021, respectively) 7,363 4,510
Total current liabilities 103,140 101,042
Notes payable, long-term (net of debt discount of $10,994 and $7,063 as of March 31, 2022 and December 31, 2021, respectively) 85,056 42,937
Operating lease liabilities, long-term 20,454 20,987
Partner company installment payments - licenses, long-term (net of imputed interest of $284 and $373 as of March 31, 2022 and December 31, 2021, respectively) 3,716 3,627
Other long-term liabilities 1,986 2,033
Total liabilities 214,352 170,626
Commitments and contingencies (Note 12)
Stockholders' equity    
Cumulative redeemable perpetual preferred stock, $.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares, 3,427,138 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively, liquidation value of $25.00 per share 3 3
Common stock, $.001 par value, 170,000,000 shares authorized, 106,321,875 and 101,435,505 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 106 101
Additional paid-in-capital 660,973 656,033
Accumulated deficit (563,223) (547,463)
Total stockholders' equity attributed to the Company 97,859 108,674
Non-controlling interests 95,719 117,203
Total stockholders' equity 193,578 225,877
Total liabilities and stockholders' equity $ 407,930 $ 396,503